The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
November 19th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
November 14th 2024
November 5th 2024
Empagliflozin Shown to Cut Mortality Risk in Long-Term CV Outcomes Trial
Surgeon General Urges Americans to Walk More to Combat Chronic Disease
CVS Unveils Deals to Expand Telehealth Services for Consumers